These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Boutros PC; Fraser M; Harding NJ; de Borja R; Trudel D; Lalonde E; Meng A; Hennings-Yeomans PH; McPherson A; Sabelnykova VY; Zia A; Fox NS; Livingstone J; Shiah YJ; Wang J; Beck TA; Have CL; Chong T; Sam M; Johns J; Timms L; Buchner N; Wong A; Watson JD; Simmons TT; P'ng C; Zafarana G; Nguyen F; Luo X; Chu KC; Prokopec SD; Sykes J; Dal Pra A; Berlin A; Brown A; Chan-Seng-Yue MA; Yousif F; Denroche RE; Chong LC; Chen GM; Jung E; Fung C; Starmans MH; Chen H; Govind SK; Hawley J; D'Costa A; Pintilie M; Waggott D; Hach F; Lambin P; Muthuswamy LB; Cooper C; Eeles R; Neal D; Tetu B; Sahinalp C; Stein LD; Fleshner N; Shah SP; Collins CC; Hudson TJ; McPherson JD; van der Kwast T; Bristow RG Nat Genet; 2015 Jul; 47(7):736-45. PubMed ID: 26005866 [TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study of germline copy number variations reveals an association with prostate cancer aggressiveness. Brezina S; Feigl M; Gumpenberger T; Staudinger R; Baierl A; Gsur A Mutagenesis; 2020 Jul; 35(3):283-290. PubMed ID: 32255470 [TBL] [Abstract][Full Text] [Related]
7. Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer. Kim TM; Jung SH; Baek IP; Lee SH; Choi YJ; Lee JY; Chung YJ; Lee SH J Pathol; 2014 Aug; 233(4):425-35. PubMed ID: 24870262 [TBL] [Abstract][Full Text] [Related]
8. Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy. Karavitakis M; Ahmed HU; Abel PD; Hazell S; Winkler MH Ther Adv Urol; 2012 Aug; 4(4):155-60. PubMed ID: 22852025 [TBL] [Abstract][Full Text] [Related]
9. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level. Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S Cells; 2020 Aug; 9(8):. PubMed ID: 32784507 [TBL] [Abstract][Full Text] [Related]
10. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Djavan B; Susani M; Bursa B; Basharkhah A; Simak R; Marberger M Tech Urol; 1999 Sep; 5(3):139-42. PubMed ID: 10527256 [TBL] [Abstract][Full Text] [Related]
11. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Liu W; Laitinen S; Khan S; Vihinen M; Kowalski J; Yu G; Chen L; Ewing CM; Eisenberger MA; Carducci MA; Nelson WG; Yegnasubramanian S; Luo J; Wang Y; Xu J; Isaacs WB; Visakorpi T; Bova GS Nat Med; 2009 May; 15(5):559-65. PubMed ID: 19363497 [TBL] [Abstract][Full Text] [Related]
12. Tumor focality is not associated with biochemical outcome after radical prostatectomy. Iremashvili V; Pelaez L; Manoharan M; Acosta K; Rosenberg DL; Soloway MS Prostate; 2012 May; 72(7):762-8. PubMed ID: 21882214 [TBL] [Abstract][Full Text] [Related]
14. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes. Wang S; Li H; Song M; Tao Z; Wu T; He Z; Zhao X; Wu K; Liu XS PLoS Genet; 2021 May; 17(5):e1009557. PubMed ID: 33945534 [TBL] [Abstract][Full Text] [Related]
15. Genomic and phenotypic heterogeneity in prostate cancer. Haffner MC; Zwart W; Roudier MP; True LD; Nelson WG; Epstein JI; De Marzo AM; Nelson PS; Yegnasubramanian S Nat Rev Urol; 2021 Feb; 18(2):79-92. PubMed ID: 33328650 [TBL] [Abstract][Full Text] [Related]
16. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing. Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308 [TBL] [Abstract][Full Text] [Related]
17. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Bostwick DG; Shan A; Qian J; Darson M; Maihle NJ; Jenkins RB; Cheng L Cancer; 1998 Nov; 83(9):1995-2002. PubMed ID: 9806659 [TBL] [Abstract][Full Text] [Related]
19. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival. Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446 [TBL] [Abstract][Full Text] [Related]
20. Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy. Ibeawuchi C; Schmidt H; Voss R; Titze U; Abbas M; Neumann J; Eltze E; Hoogland AM; Jenster G; Brandt B; Semjonow A Int J Mol Sci; 2015 Feb; 16(2):3856-69. PubMed ID: 25679447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]